Accenture Stock Gets Price Target Cuts Amid AI Debate
Accenture beat on earnings and bookings, but two major firms trimmed price targets as investors weigh AI’s effect on ...
Which Is Better Emergency Or Sinking Fund
Assess the pros and cons of emergency versus sinking funds to determine which is more suitable for your goals, and how to combine them effectively.
23,703 articles
United Airlines Slashes Flights Amid Fuel-Cost Surge
United Airlines will cut about 5% of capacity this quarter as jet fuel prices climb amid geopolitical tensions. The m...
Apple Praises China Partners Amid Beijing Pressure
Tim Cook used the China Development Forum to stress collaboration with Chinese partners as Beijing intensifies policy...
Billionaire Reddit Steve Huffman Bets Heavily on AI Grads
Reddit plans a major expansion of its new-grad hiring, arguing AI-native graduates can accelerate product development...
Grab Expands Taiwan, First Non-SE Asia Market Deal
Grab lands its first expansion outside Southeast Asia by acquiring Foodpanda Taiwan for $600 million, targeting a lat...
Housing Needs Fifth Place: Builders Design Belonging
Developers shift from splashy amenities to intentional spaces that foster belonging, a move that also redefines how l...
Sell-Off: Stocks Investors Should Load Up on AI Bets
The AI rally cooled, but the opportunity remains. This guide shares three AI stocks investors should load up on and a...
Citi Cuts Target for Super Micro Computer to $25 Amid Probe
Citi trims its price target for Super Micro Computer to $25 from $39, citing governance and export-control concerns e...
Type Cryptocurrency Avoid Costs: One to Watch in 2026
In 2026, the crypto market offers many opportunities, but not all are worth your money. This guide explains why a sin...
Wall Street Cuts Mosaic Again: UBS Slashes Target to $27
UBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
Bitcoin Faces Billion Options Expiry Amid Global Tensions
Roughly $14 billion in Bitcoin options are set to expire this week, complicating the market as Middle East tensions a...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status